Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboembolism.

James Drife1

  • 1Department of Obstetrics and Gynaecology, University of Leeds, Leeds, UK. j.o.drife@leeds.ac.uk

British Medical Bulletin
|January 9, 2004
PubMed
Summary
This summary is machine-generated.

Venous thromboembolism (VTE) is a significant cause of maternal death in developed nations. Risk assessment and thromboprophylaxis are crucial for preventing VTE during pregnancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phantom Fetal Movements and Pregnancy Surveillance.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

On published research: a BOGSAT perspective.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Deep venous thrombosis and pulmonary embolism in obese women.

Best practice & research. Clinical obstetrics & gynaecology·2014
Same author

Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom.

BJOG : an international journal of obstetrics and gynaecology·2011
Same author

Improving maternal and perinatal health care in the Central Asian republics.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2010
Same author

Maternal mortality in well-resourced countries: is there still a need for confidential enquiries?

Best practice & research. Clinical obstetrics & gynaecology·2008
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Public Health

Background:

  • Venous thromboembolism (VTE) presents a significant cause of direct maternal mortality in developed countries, though a smaller percentage in developing nations.
  • Pregnancy inherently elevates VTE risk due to physiological changes like venous stasis and altered blood coagulability.
  • Clinical diagnosis of VTE in pregnancy is often unreliable, necessitating objective testing for accurate identification.

Purpose of the Study:

  • To highlight the importance of VTE awareness and objective testing in pregnant women.
  • To discuss the safe and effective management of VTE during pregnancy.
  • To advocate for universal risk assessment and thromboprophylaxis strategies in pregnant individuals.

Main Methods:

  • Diagnostic methods include compression or duplex ultrasonography for deep venous thrombosis and ventilation/perfusion scans for pulmonary embolism.

Related Experiment Videos

  • Low molecular weight heparins are identified as safe and effective treatments and prophylactic agents.
  • Risk assessment protocols are recommended for all women, ideally before or in early pregnancy.

    • Main Results:

    • Risk assessment identifies factors such as obesity and a history of thromboembolism, enabling targeted thromboprophylaxis.
    • Established guidelines for thromboprophylaxis have successfully reduced maternal deaths post-cesarean section.
    • Development of comprehensive guidelines for all pregnant women is underway.

    Conclusions:

    • Early risk assessment and appropriate thromboprophylaxis are vital for mitigating maternal VTE risks.
    • Objective diagnostic tools and safe pharmacological interventions are key to managing VTE in pregnancy.
    • Standardized guidelines are essential for improving maternal outcomes related to VTE.